Editas Medicine Inc. (NASDAQ: EDIT) announced that five abstracts have been accepted for presentation at upcoming scientific conferences, focusing on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE